Literature DB >> 18996768

Laparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease.

J Esteban Varela1, Marcelo W Hinojosa, Ninh T Nguyen.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is commonly associated with morbid obesity. Laparoscopic fundoplication is a standard surgical treatment for GERD, and laparoscopic gastric bypass has been shown to effectively resolve GERD symptoms in the morbidly obese. We sought to compare the in-hospital outcomes of morbidly obese patients who underwent laparoscopic fundoplication for the treatment of GERD versus laparoscopic gastric bypass for the treatment of morbid obesity and related conditions, including GERD, at U.S. academic medical centers.
METHODS: Using the "International Classification of Diseases, 9th Revision" procedural and diagnoses codes for morbidly obese patients with GERD, we obtained data from the University HealthSystem Consortium database for all patients who underwent laparoscopic fundoplication or laparoscopic gastric bypass from October 2004 to December 2007 (n=27,264). The outcome measures included the patient demographics, length of stay, in-hospital overall complications, mortality, risk-adjusted mortality ratio (observed to expected mortality), and hospital costs.
RESULTS: Compared with the patients who underwent laparoscopic gastric bypass, those who underwent laparoscopic fundoplication had a lower severity of illness score (P<.05). The overall in-hospital complications were significantly lower in the laparoscopic gastric bypass group (P<.05). The mean length of stay, observed mortality, risk-adjusted mortality, and hospital costs were comparable between the 2 treatment groups.
CONCLUSION: Laparoscopic gastric bypass is as safe as laparoscopic fundoplication for the treatment of GERD in the morbidly obese. Hence, morbidly obese patients with GERD should be referred for bariatric surgery evaluation and offered laparoscopic gastric bypass as a surgical option.

Entities:  

Mesh:

Year:  2008        PMID: 18996768     DOI: 10.1016/j.soard.2008.08.021

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  30 in total

1.  Morbidity and mortality associated with antireflux surgery with or without paraesophogeal hernia: a large ACS NSQIP analysis.

Authors:  Anne O Lidor; David C Chang; Richard L Feinberg; Kimberley E Steele; Michael A Schweitzer; Marianne M Franco
Journal:  Surg Endosc       Date:  2011-04-22       Impact factor: 4.584

Review 2.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

3.  Advances in GERD: Current Developments in the Management of Acid-Related GI Disorders.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

4.  Moderating the Enthusiasm of Sleeve Gastrectomy: Up to Fifty Percent of Reflux Symptoms After Ten Years in a Consecutive Series of One Hundred Laparoscopic Sleeve Gastrectomies.

Authors:  Yannick Mandeville; Ruth Van Looveren; Peter-Jan Vancoillie; Xander Verbeke; Katrien Vandendriessche; Patrick Vuylsteke; Paul Pattyn; Bart Smet
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

Review 5.  Patients Having Bariatric Surgery: Surgical Options in Morbidly Obese Patients with Barrett's Esophagus.

Authors:  I Braghetto; A Csendes
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

6.  Laparoscopic Nissen Fundoplication Plus Mid-gastric Plication for Treatment of Obese Patients with Gastroesophageal Reflux Disease.

Authors:  Ahmed Talha; Mohammed Ibrahim
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

Review 7.  Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence.

Authors:  Wei-Jei Lee; Yu-Hung Lin
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

Review 8.  Surgical Anti-Reflux Options Beyond Fundoplication.

Authors:  Dan Azagury; John Morton
Journal:  Curr Gastroenterol Rep       Date:  2017-07

9.  Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients.

Authors:  Italo Braghetto; Enrique Lanzarini; Owen Korn; Héctor Valladares; Juan Carlos Molina; Ana Henriquez
Journal:  Obes Surg       Date:  2009-12-15       Impact factor: 4.129

Review 10.  The Improvement of Gastroesophageal Reflux Disease and Barrett's after Bariatric Surgery.

Authors:  Tammy L Kindel; Dmitry Oleynikov
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.